Global Partners Join Forces to Speed Development of New TB Drug Combinations
FDA applauds effort to take years off development of much needed TB treatments
Related Posts
-
CPTR Newsletter – April 2018 -
For Two Arizona-Based Nonprofits, Past Meets Present on World TB Day -
New Clinical Infectious Diseases Journal Supplement Highlights Hollow Fiber System Model for Tuberculosis -
C-Path, CDISC launch “breakthrough” tool for TB drug development -
Renewed Focus on Tuberculosis Holds Promise for New Treatments